Does Risk of Progression from Barrett’s Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?

被引：0
作者：
Andrew T. Kunzmann
Helen G. Coleman
Brian T. Johnston
Richard C. Turkington
Damian McManus
Lesley A. Anderson
Aaron P. Thrift
机构：
[1] Queen’s University Belfast,Institute of Clinical Sciences Block B, Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Royal Victoria Hospital
[2] Queen’s University Belfast,Centre for Cancer Research and Cell Biology
[3] Belfast Health & Social Care Trust,Royal Victoria Hospital
[4] Belfast Health & Social Care Trust,Belfast City Hospital
[5] Belfast Health & Social Care Trust,Department of Pathology
[6] Queen’s University Belfast,Northern Ireland Cancer Registry
[7] Baylor College of Medicine,Section of Epidemiology and Population Sciences, Department of Medicine
[8] Baylor College of Medicine,Dan L Duncan Comprehensive Cancer Center
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Barrett’s esophagus; Endoscopic surveillance; Epidemiology; Esophageal adenocarcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1965 / 1973
页数：8
相关论文
共 50 条
[1]  
Fitzgerald RC(2014)British society of gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus Gut 63 7-42
[2]  
Di Pietro M(2016)ACG clinical guideline: diagnosis and management of Barrett’s esophagus Am J Gastroenterol 111 30-50
[3]  
Ragunath K(2011)Increasing incidence of Barrett’s oesophagus: a population-based study Eur J Epidemiol 26 739-745
[4]  
Shaheen NJ(2011)Is endoscopic surveillance for non-dysplastic Barrett’s esophagus cost-effective? Review of economic evaluations J Gastroenterol Hepatol 26 247-254
[5]  
Falk GW(2014)Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett’s esophagus Gastrointest Endosc 79 242e6-256.e6
[6]  
Iyer PG(2017)Persistence of nondysplastic Barrett’s esophagus is not protective against progression to adenocarcinoma Clin Gastroenterol Hepatol 15 950-952
[7]  
Coleman HG(2017)The annual risk of esophageal adenocarcinoma does not decrease over time in patients with Barrett’s esophagus Am J Gastroenterol 112 1049-1055
[8]  
Bhat S(2011)Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study J Natl Cancer Inst 103 1049-1057
[9]  
Murray LJ(2011)Incidence of adenocarcinoma among patients with Barrett’s esophagus N Engl J Med 365 1375-1383
[10]  
Hirst NG(2013)Persistence of nondysplastic Barrett’s esophagus identifies patients at lower risk for Esophageal adenocarcinoma: Results from a large multicenter cohort Gastroenterology 145 548-553.e1
12345